...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Vote reminder

Toinv

Past tense was 2022. You can attend the 2023 meeting in Calgary this coming Thur or view the corporate presentation afterwards. Let's hear some good news!

Chicagoest

Share
New Message
Please login to post a reply